Welcome to our dedicated page for American Fusion news (Ticker: AMFN), a resource for investors and traders seeking the latest updates and insights on American Fusion stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect American Fusion's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of American Fusion's position in the market.
American Fusion (OTC: AMFN) says it is in final discussions to secure multi-year supply contracts for helium-3 and deuterium to fuel its Texatron aneutronic fusion system, aiming to reduce long-term operational uncertainty and support commercialization.
The company also reported recent Delaware Court of Chancery rulings denying expedited relief, filed a motion for injunctive relief on April 1, and expects court-ordered share cancellations to be reflected in its records.
American Fusion (OTC: AMFN) obtained a court order cancelling 1,683,000,000 improperly issued common shares, a move the company says removes more than half of outstanding stock and restores its capitalization table. The court entered the order in March 2026, and the company expects transfer-agent records updated before quarter-end.
Additional milestones: completion of a two-year PCAOB audit, a Feb 27, 2026 business combination with Kepler Fusion Technologies, a Form 10 filing expected to become effective on May 14, 2026, and planned 10-Q filing by May 15, 2026.
American Fusion (OTC: AMFN) received SEC notice that its Form 10-12G filed March 16, 2026, will receive a “no review” designation and is expected to become effective automatically on May 14, 2026. Upon effectiveness, the company will be subject to full Exchange Act reporting, including Form 10-Q and 10-K obligations.
The company expects its first Form 10-Q for the quarter ended March 31, 2026, to reflect the February share-exchange merger and newly acquired technology and IP, and views SEC reporting as a step toward OTCQB uplisting and potential Form 211 sponsorship while engaging investment banks for capital and listing advice.
American Fusion (OTC: AMFN) provided an update on industry engagements on March 24, 2026. Representatives are attending IWAHLM-17 in Bergamo, Italy (March 24–26) and APEC in San Antonio, Texas (March 22–26). The company said these activities support technical networking, monitoring adjacent technologies, and relationship-building.
American Fusion (OTC: AMFN) appointed Michael Carlson as Chief Financial Officer on March 23, 2026. Mr. Carlson brings 30+ years in corporate finance, including a €795 million refinancing and leadership roles at Budapest Airport and KPMG.
The company completed PCAOB audits for fiscal years 2024 and 2025, filed a Form 10 registration, and reported mixed legal developments including a Delaware Court denial of expedited relief and a pending Washington State hearing outcome.